サンプル依頼リスト カート
  • English
  • Korean
  • Traditional Chinese
  • Simplified Chinese
デフォルト表紙
市場調査レポート
商品コード
1703482

フシジン酸市場- 世界の産業規模、シェア、動向、機会、予測、販売チャネル別（直接、間接）、最終用途別（膿痂疹、蜂窩織炎、切り傷・創傷、眼感染、その他）、地域別、競合別、2020-2030F

Fusidic Acid Market - Global Industry Size, Share, Trends, Opportunity, and Forecast, Segmented By Sales Channel (Direct, Indirect), By End Use (Impetigo, Cellulitis, Cuts & Wounds, Eye Infection, Others), By Region and Competition, 2020-2030F

出版日
ページ情報
英文 185 Pages
納期
2～3営業日
カスタマイズ可能
価格
価格表記: USDを日本円(税抜)に換算
本日の銀行送金レート: 1USD=146.99円

こちらのレポートには、数時間（ご購入金額の10%）分のアナリストへの質問／追加調査サービスが含まれております。

フシジン酸市場- 世界の産業規模、シェア、動向、機会、予測、販売チャネル別（直接、間接）、最終用途別（膿痂疹、蜂窩織炎、切り傷・創傷、眼感染、その他）、地域別、競合別、2020-2030F
出版日: 2025年04月11日
発行: TechSci Research
ページ情報: 英文 185 Pages
納期: 2～3営業日
GIIご利用のメリット
  • 全表示
  • 概要
  • 目次
概要

フシジン酸の世界市場は、2024年に2,971万米ドルと評価され、2030年には4,212万米ドルに達すると予測され、予測期間中に2.02％の年間複合成長率（CAGR）で成長すると予測されています。

市場成長は、特に皮膚や軟部組織に影響を及ぼす細菌感染症の治療におけるフシジン酸の用途拡大が着実に牽引しています。

市場概要
予測期間 2026-2030
市場規模：2024年 2,971万米ドル
市場規模：2030年 4,212万米ドル
CAGR：2025年～2030年 2.02%
急成長セグメント ダイレクト
最大市場 アジア太平洋

フシジン酸は、主にメチシリン耐性株（MRSA）を含む黄色ブドウ球菌による感染症の治療に使用される強力な抗生物質で、外用剤と経口剤の両方が一般的に入手可能であり、病院と地域社会の両方で懸念が高まっています。抗生物質耐性が世界の問題として深刻化する中、フシジン酸のような効果的な代替薬の必要性が高まっています。

この抗生物質は医薬品や皮膚科製剤に広く使用されており、特に伝染性膿痂疹、毛嚢炎、蜂窩織炎などの皮膚疾患の治療に重点を置いています。世界人口の高齢化と相まって、これらの感染症の罹患率が上昇しており、様々な地域でフシジン酸の需要を促進しています。さらに、抗生物質耐性をめぐる意識の高まりが、フシジン酸に基づく治療への関心を高めています。世界市場の特徴は、ブランド品とジェネリック医薬品が混在していることであり、ジェネリック医薬品はその手頃な価格と幅広い入手可能性により、ますます支持を集めています。

主な市場促進要因

世界のヘルスケア産業の拡大

主な市場課題

安全性への懸念と副作用

主要市場動向

眼感染症の増加

目次

第1章 概要

第2章 調査手法

第3章 エグゼクティブサマリー

第4章 COVID-19が世界のフシジン酸市場に与える影響

第5章 世界のフシジン酸市場展望

  • 市場規模・予測
    • 金額別
  • 市場シェア・予測
    • 販売チャネル別（直接、間接）
    • 用途別（伝染性膿痂疹、蜂窩織炎、切り傷、眼感染症、その他）
    • 地域別
    • 企業別（2024）
  • 市場マップ

第6章 北米のフシジン酸市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 北米：国別分析
    • 米国
    • メキシコ
    • カナダ

第7章 欧州のフシジン酸市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 欧州：国別分析
    • フランス
    • ドイツ
    • 英国
    • イタリア
    • スペイン

第8章 アジア太平洋地域のフシジン酸市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • アジア太平洋地域：国別分析
    • 中国
    • インド
    • 韓国
    • 日本
    • オーストラリア

第9章 南米のフシジン酸市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 南米：国別分析
    • ブラジル
    • アルゼンチン
    • コロンビア

第10章 中東・アフリカのフシジン酸市場展望

  • 市場規模・予測
  • 市場シェア・予測
  • 中東・アフリカ：国別分析
    • 南アフリカ
    • サウジアラビア
    • アラブ首長国連邦

第11章 市場力学

  • 促進要因
  • 課題

第12章 市場動向と発展

  • 合併と買収
  • 製品上市
  • 最近の動向

第13章 世界のフシジン酸市場：SWOT分析

第14章 ポーターのファイブフォース分析

  • 業界内の競合
  • 新規参入の可能性
  • サプライヤーの力
  • 顧客の力
  • 代替品の脅威

第15章 競合情勢

  • Ercros S.A
  • Emote Life sciences LLP
  • Kaniwa Bioscience Pvt. Ltd
  • Concord Biotech Limited
  • Fleming Laboratories Ltd
  • Sterling Biotech Ltd
  • Oliver Pharmaceuticals
  • Apex Healthcare Ltd
  • Horster Life Sciences Pvt. Ltd.
  • Celaxis Bioscience Pvt Ltd

第16章 戦略的提言

第17章 調査会社について・免責事項

目次
Product Code: 28286

Global Fusidic Acid Market was valued at USD 29.71 million in 2024 and is projected to reach USD 42.12 million by 2030, growing at a compound annual growth rate (CAGR) of 2.02% over the forecast period. Market growth is being steadily driven by the increasing application of fusidic acid in treating bacterial infections, particularly those affecting the skin and soft tissues.

Market Overview
Forecast Period2026-2030
Market Size 2024USD 29.71 Million
Market Size 2030USD 42.12 Million
CAGR 2025-20302.02%
Fastest Growing SegmentDirect
Largest MarketAsia-Pacific

Fusidic acid is a potent antibiotic commonly available in both topical and oral formulations, primarily used to treat infections caused by Staphylococcus aureus, including methicillin-resistant strains (MRSA), which are a growing concern in both hospital and community settings. As antibiotic resistance becomes an escalating global issue, the need for effective alternatives such as fusidic acid is gaining momentum.

This antibiotic is widely used in pharmaceutical and dermatological formulations, with a particular focus on treating skin conditions like impetigo, folliculitis, and cellulitis. The rising incidence of these infections, coupled with an aging global population, is fueling demand for fusidic acid across various geographies. Additionally, heightened awareness surrounding antibiotic resistance has intensified interest in fusidic acid-based treatments. The global market is characterized by a mix of branded and generic products, with generic formulations increasingly gaining traction due to their affordability and broader availability.

Key Market Drivers

Expansion of the Global Healthcare Industry

The ongoing growth of the global healthcare sector is a significant catalyst for the fusidic acid market. Worldwide healthcare sales are projected to surpass USD 4 trillion annually, with pharmaceuticals and biotechnology representing the most substantial segments-generating close to USD 850 billion-followed by medical technology and diagnostics at over USD 400 billion.

Fusidic acid is recognized as a valuable therapeutic solution for a range of bacterial infections, including skin, eye, and soft tissue infections. As the demand for targeted and effective treatments rises, driven by the increasing incidence of bacterial infections and improvements in healthcare infrastructure and accessibility, the market for fusidic acid continues to expand.

Key Market Challenges

Safety Concerns and Adverse Effects

One of the primary concerns surrounding the use of fusidic acid is its potential hepatotoxicity. Prolonged use or high dosages can lead to liver complications such as hepatitis or jaundice-particularly in patients with existing liver conditions, thereby increasing the risk of adverse reactions. As a result, patients undergoing treatment with fusidic acid often require regular liver function monitoring to mitigate risks.

These safety considerations limit the duration for which fusidic acid can be prescribed, posing challenges in cases that demand long-term antibiotic therapy. In addition, while topical formulations are widely used for skin infections, they can cause local side effects such as irritation, redness, itching, or rashes-sometimes resulting in treatment discontinuation among sensitive individuals.

Although rare, allergic reactions-including severe responses such as anaphylaxis-can occur, especially in immunocompromised populations. These potential risks may hinder wider market adoption. To address this, manufacturers must implement clear labeling, patient education, and effective monitoring practices to ensure safe and informed usage.

Key Market Trends

Rising Incidence of Eye Infections

A notable trend propelling the global fusidic acid market is the increasing prevalence of bacterial eye infections. According to the World Health Organization (WHO), trachoma alone is responsible for approximately 1.9 million cases of blindness or visual impairment across 42 countries, representing 1.4% of global blindness. The economic burden associated with this condition is estimated between USD 2.9 billion and USD 5.3 billion annually.

Bacterial eye infections caused by pathogens such as Staphylococcus aureus and Streptococcus pneumoniae are on the rise due to several factors, including environmental pollution, rapid urbanization, and lifestyle-related changes. Fusidic acid, known for its efficacy in treating localized bacterial infections, has emerged as a key solution for conditions such as bacterial conjunctivitis, blepharitis, and keratitis.

This upward trend is further supported by increasing exposure to environmental irritants, allergens, and extended screen time, all of which contribute to eye dryness and a higher risk of infection. Additionally, the growing global use of contact lenses-particularly in urban populations-has led to a rise in bacterial eye infections linked to poor hygiene and prolonged wear. These factors are driving the demand for fusidic acid-based ophthalmic treatments, reinforcing its role in the evolving landscape of infectious disease management.

Key Market Players

  • Ercros S.A
  • Emote Life sciences LLP
  • Kaniwa Bioscience Pvt. Ltd
  • Concord Biotech Limited
  • Fleming Laboratories Ltd
  • Sterling Biotech Ltd
  • Oliver Pharmaceuticals
  • Apex Healthcare Ltd
  • Horster Life Sciences Pvt. Ltd.
  • Celaxis Bioscience Pvt Ltd

Report Scope

In this report, the Global Fusidic Acid Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Fusidic Acid Market, By Sales Channel:

  • Direct
  • Indirect

Fusidic Acid Market, By End Use:

  • Impetigo
  • Cellulitis
  • Cuts & Wounds
  • Eye Infection
  • Others

Fusidic Acid Market, By Region:

  • North America
    • United States
    • Canada
    • Mexico
  • Europe
    • France
    • United Kingdom
    • Italy
    • Germany
    • Spain
  • Asia Pacific
    • China
    • India
    • Japan
    • Australia
    • South Korea
  • South America
    • Brazil
    • Argentina
    • Colombia
  • Middle East & Africa
    • South Africa
    • Saudi Arabia
    • UAE

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Fusidic Acid Market.

Available Customizations:

Global Fusidic Acid Market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

  • Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

  • 1.1. Market Definition
  • 1.2. Scope of the Market
    • 1.2.1. Markets Covered
    • 1.2.2. Years Considered for Study
    • 1.2.3. Key Market Segmentations

2. Research Methodology

  • 2.1. Objective of the Study
  • 2.2. Baseline Methodology
  • 2.3. Key Industry Partners
  • 2.4. Major Association and Secondary Sources
  • 2.5. Forecasting Methodology
  • 2.6. Data Triangulation & Validation
  • 2.7. Assumptions and Limitations

3. Executive Summary

  • 3.1. Overview of the Market
  • 3.2. Overview of Key Market Segmentations
  • 3.3. Overview of Key Market Players
  • 3.4. Overview of Key Regions/Countries
  • 3.5. Overview of Market Drivers, Challenges, and Trends

4. Impact of COVID-19 on Global Fusidic Acid Market

5. Global Fusidic Acid Market Outlook

  • 5.1. Market Size & Forecast
    • 5.1.1. By Value
  • 5.2. Market Share & Forecast
    • 5.2.1. By Sales Channel (Direct, Indirect)
    • 5.2.2. By End Use (Impetigo, Cellulitis, Cuts & Wounds, Eye Infection, Others)
    • 5.2.3. By Region
    • 5.2.4. By Company (2024)
  • 5.3. Market Map

6. North America Fusidic Acid Market Outlook

  • 6.1. Market Size & Forecast
    • 6.1.1. By Value
  • 6.2. Market Share & Forecast
    • 6.2.1. By Sales Channel
    • 6.2.2. By End Use
    • 6.2.3. By Country
  • 6.3. North America: Country Analysis
    • 6.3.1. United States Fusidic Acid Market Outlook
      • 6.3.1.1. Market Size & Forecast
        • 6.3.1.1.1. By Value
      • 6.3.1.2. Market Share & Forecast
        • 6.3.1.2.1. By Sales Channel
        • 6.3.1.2.2. By End Use
    • 6.3.2. Mexico Fusidic Acid Market Outlook
      • 6.3.2.1. Market Size & Forecast
        • 6.3.2.1.1. By Value
      • 6.3.2.2. Market Share & Forecast
        • 6.3.2.2.1. By Sales Channel
        • 6.3.2.2.2. By End Use
    • 6.3.3. Canada Fusidic Acid Market Outlook
      • 6.3.3.1. Market Size & Forecast
        • 6.3.3.1.1. By Value
      • 6.3.3.2. Market Share & Forecast
        • 6.3.3.2.1. By Sales Channel
        • 6.3.3.2.2. By End Use

7. Europe Fusidic Acid Market Outlook

  • 7.1. Market Size & Forecast
    • 7.1.1. By Value
  • 7.2. Market Share & Forecast
    • 7.2.1. By Sales Channel
    • 7.2.2. By End Use
    • 7.2.3. By Country
  • 7.3. Europe: Country Analysis
    • 7.3.1. France Fusidic Acid Market Outlook
      • 7.3.1.1. Market Size & Forecast
        • 7.3.1.1.1. By Value
      • 7.3.1.2. Market Share & Forecast
        • 7.3.1.2.1. By Sales Channel
        • 7.3.1.2.2. By End Use
    • 7.3.2. Germany Fusidic Acid Market Outlook
      • 7.3.2.1. Market Size & Forecast
        • 7.3.2.1.1. By Value
      • 7.3.2.2. Market Share & Forecast
        • 7.3.2.2.1. By Sales Channel
        • 7.3.2.2.2. By End Use
    • 7.3.3. United Kingdom Fusidic Acid Market Outlook
      • 7.3.3.1. Market Size & Forecast
        • 7.3.3.1.1. By Value
      • 7.3.3.2. Market Share & Forecast
        • 7.3.3.2.1. By Sales Channel
        • 7.3.3.2.2. By End Use
    • 7.3.4. Italy Fusidic Acid Market Outlook
      • 7.3.4.1. Market Size & Forecast
        • 7.3.4.1.1. By Value
      • 7.3.4.2. Market Share & Forecast
        • 7.3.4.2.1. By Sales Channel
        • 7.3.4.2.2. By End Use
    • 7.3.5. Spain Fusidic Acid Market Outlook
      • 7.3.5.1. Market Size & Forecast
        • 7.3.5.1.1. By Value
      • 7.3.5.2. Market Share & Forecast
        • 7.3.5.2.1. By Sales Channel
        • 7.3.5.2.2. By End Use

8. Asia Pacific Fusidic Acid Market Outlook

  • 8.1. Market Size & Forecast
    • 8.1.1. By Value
  • 8.2. Market Share & Forecast
    • 8.2.1. By Sales Channel
    • 8.2.2. By End Use
    • 8.2.3. By Country
  • 8.3. Asia Pacific: Country Analysis
    • 8.3.1. China Fusidic Acid Market Outlook
      • 8.3.1.1. Market Size & Forecast
        • 8.3.1.1.1. By Value
      • 8.3.1.2. Market Share & Forecast
        • 8.3.1.2.1. By Sales Channel
        • 8.3.1.2.2. By End Use
    • 8.3.2. India Fusidic Acid Market Outlook
      • 8.3.2.1. Market Size & Forecast
        • 8.3.2.1.1. By Value
      • 8.3.2.2. Market Share & Forecast
        • 8.3.2.2.1. By Sales Channel
        • 8.3.2.2.2. By End Use
    • 8.3.3. South Korea Fusidic Acid Market Outlook
      • 8.3.3.1. Market Size & Forecast
        • 8.3.3.1.1. By Value
      • 8.3.3.2. Market Share & Forecast
        • 8.3.3.2.1. By Sales Channel
        • 8.3.3.2.2. By End Use
    • 8.3.4. Japan Fusidic Acid Market Outlook
      • 8.3.4.1. Market Size & Forecast
        • 8.3.4.1.1. By Value
      • 8.3.4.2. Market Share & Forecast
        • 8.3.4.2.1. By Sales Channel
        • 8.3.4.2.2. By End Use
    • 8.3.5. Australia Fusidic Acid Market Outlook
      • 8.3.5.1. Market Size & Forecast
        • 8.3.5.1.1. By Value
      • 8.3.5.2. Market Share & Forecast
        • 8.3.5.2.1. By Sales Channel
        • 8.3.5.2.2. By End Use

9. South America Fusidic Acid Market Outlook

  • 9.1. Market Size & Forecast
    • 9.1.1. By Value
  • 9.2. Market Share & Forecast
    • 9.2.1. By Sales Channel
    • 9.2.2. By End Use
    • 9.2.3. By Country
  • 9.3. South America: Country Analysis
    • 9.3.1. Brazil Fusidic Acid Market Outlook
      • 9.3.1.1. Market Size & Forecast
        • 9.3.1.1.1. By Value
      • 9.3.1.2. Market Share & Forecast
        • 9.3.1.2.1. By Sales Channel
        • 9.3.1.2.2. By End Use
    • 9.3.2. Argentina Fusidic Acid Market Outlook
      • 9.3.2.1. Market Size & Forecast
        • 9.3.2.1.1. By Value
      • 9.3.2.2. Market Share & Forecast
        • 9.3.2.2.1. By Sales Channel
        • 9.3.2.2.2. By End Use
    • 9.3.3. Colombia Fusidic Acid Market Outlook
      • 9.3.3.1. Market Size & Forecast
        • 9.3.3.1.1. By Value
      • 9.3.3.2. Market Share & Forecast
        • 9.3.3.2.1. By Sales Channel
        • 9.3.3.2.2. By End Use

10. Middle East and Africa Fusidic Acid Market Outlook

  • 10.1. Market Size & Forecast
    • 10.1.1. By Value
  • 10.2. Market Share & Forecast
    • 10.2.1. By Sales Channel
    • 10.2.2. By End Use
    • 10.2.3. By Country
  • 10.3. MEA: Country Analysis
    • 10.3.1. South Africa Fusidic Acid Market Outlook
      • 10.3.1.1. Market Size & Forecast
        • 10.3.1.1.1. By Value
      • 10.3.1.2. Market Share & Forecast
        • 10.3.1.2.1. By Sales Channel
        • 10.3.1.2.2. By End Use
    • 10.3.2. Saudi Arabia Fusidic Acid Market Outlook
      • 10.3.2.1. Market Size & Forecast
        • 10.3.2.1.1. By Value
      • 10.3.2.2. Market Share & Forecast
        • 10.3.2.2.1. By Sales Channel
        • 10.3.2.2.2. By End Use
    • 10.3.3. UAE Fusidic Acid Market Outlook
      • 10.3.3.1. Market Size & Forecast
        • 10.3.3.1.1. By Value
      • 10.3.3.2. Market Share & Forecast
        • 10.3.3.2.1. By Sales Channel
        • 10.3.3.2.2. By End Use

11. Market Dynamics

  • 11.1. Drivers
  • 11.2. Challenges

12. Market Trends & Developments

  • 12.1. Merger & Acquisition (If Any)
  • 12.2. Product Launches (If Any)
  • 12.3. Recent Developments

13. Global Fusidic Acid Market: SWOT Analysis

14. Porters Five Forces Analysis

  • 14.1. Competition in the Industry
  • 14.2. Potential of New Entrants
  • 14.3. Power of Suppliers
  • 14.4. Power of Customers
  • 14.5. Threat of Substitute Products

15. Competitive Landscape

  • 15.1. Ercros S.A
    • 15.1.1. Business Overview
    • 15.1.2. Company Snapshot
    • 15.1.3. Products & Services
    • 15.1.4. Financials (As Reported)
    • 15.1.5. Recent Developments
    • 15.1.6. Key Personnel Details
    • 15.1.7. SWOT Analysis
  • 15.2. Emote Life sciences LLP
  • 15.3. Kaniwa Bioscience Pvt. Ltd
  • 15.4. Concord Biotech Limited
  • 15.5. Fleming Laboratories Ltd
  • 15.6. Sterling Biotech Ltd
  • 15.7. Oliver Pharmaceuticals
  • 15.8. Apex Healthcare Ltd
  • 15.9. Horster Life Sciences Pvt. Ltd.
  • 15.10. Celaxis Bioscience Pvt Ltd

16. Strategic Recommendations

17. About Us & Disclaimer